• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 490399 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416590971 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416590971 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Acorda Therapeutics Shares Sinking Lower, Down 2.6%

Published on Wed, 05/01/2013 - 10:30
By Adrienne Chilton

Acorda Therapeutics (NASDAQ:ACOR), a company whose shares are moving quickly, is trading 2.6% lower to $38.54. The Dow Jones Industrial Average is now trading 0.4% lower to 14,781 and the S&P is trading 0.4% lower to 1,591.

Acorda Therapeutics (NASDAQ:ACOR) is currently priced 16.6% above its average consensus analyst price target of $32.14. The stock should find initial support at its 50-day moving average (MA) of $32.69 and further support at its 200-day MA of $27.13.

In the past 52 weeks, shares of Acorda Therapeutics have traded between a low of $21.04 and a high of $40.87 and are now at $38.54, which is 83% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 1.8% while the 200-day MA has risen 0.7%.

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Bullish Moving Average Cross by Brown-Fo...

Brown-Forman (NYSE:BF.B) crossed over its 10-day moving average of $94.10 on a volume o ...

Shares of Net 1 UEPS Technologies Receiv...

Net 1 UEPS Technologies (NASDAQ:UEPS) is one of today's biggest movers, up 1.9% to $12. ...

United Continental Holdings Crosses Belo...

United Continental Holdings (NYSE:UAL) shares have crossed bearishly below their 10-day ...

HMS Holdings Makes a Move: Up 1.9%...

HMS Holdings (NASDAQ:HMSY), a company whose shares are moving quickly, is trading 1.9% ...

Stock Investors Bid Up Shares of Keryx B...

Keryx Biopharmaceuticals (NASDAQ:KERX), a company whose shares are moving quickly, is t ...

Bullish Moving Average Cross by SunTrust...

Today, shares of SunTrust Banks (NYSE:STI) have crossed bullishly above their 10-day mo ...

Stock Investors Bid Up Shares of Agnico-...

Agnico-Eagle Mines (NYSE:AEM), a company whose shares are moving quickly, is trading 1. ...

AvalonBay Communities Bullish Moving Ave...

Today, shares of AvalonBay Communities (NYSE:AVB) have crossed bullishly above their 10 ...